仙琚制药
(002332)
| 流通市值：86.55亿 | | | 总市值：86.85亿 |
| 流通股本：9.86亿 | | | 总股本：9.89亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 2,928,372,588.69 | 1,958,633,864.22 | 918,349,166.84 | 3,758,969,165.42 |
| 营业总成本 | 2,470,176,318.76 | 1,634,971,949.57 | 810,954,601.33 | 3,292,197,358.83 |
| 其他经营收益 | | | | |
| 营业利润 | 434,368,222.28 | 293,144,056.21 | 109,432,199.07 | 472,358,498.38 |
| 利润总额 | 504,406,721.06 | 289,747,260.76 | 108,302,673.21 | 535,841,053.13 |
| 净利润 | 418,665,937.15 | 244,585,180.06 | 90,368,537.62 | 452,603,660.56 |
| 每股收益 | | | | |
| 其他综合收益 | -113,218,605.54 | -84,440,890.22 | -50,090,940.43 | 127,106,783.52 |
| 综合收益总额 | 305,447,331.61 | 160,144,289.84 | 40,277,597.19 | 579,710,444.08 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 3,230,799,766.02 | 3,213,659,862.96 | 3,354,994,372.9 | 3,302,769,300.75 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,848,778,421.51 | 3,873,432,580.95 | 3,910,149,098.12 | 3,956,078,955.97 |
| 资产总计 | 7,079,578,187.53 | 7,087,092,443.91 | 7,265,143,471.02 | 7,258,848,256.72 |
| 流动负债: | | | | |
| 流动负债合计 | 864,255,999.72 | 876,751,400.37 | 1,010,103,734.51 | 1,048,984,006.44 |
| 非流动负债: | | | | |
| 非流动负债合计 | 275,148,430.96 | 202,877,978.51 | 132,669,846.88 | 127,771,957.84 |
| 负债合计 | 1,139,404,430.68 | 1,079,629,378.88 | 1,142,773,581.39 | 1,176,755,964.28 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 5,899,140,674.62 | 5,962,848,879.59 | 6,078,905,621.22 | 6,035,110,264.68 |
| 股东权益合计 | 5,940,173,756.85 | 6,007,463,065.03 | 6,122,369,889.63 | 6,082,092,292.44 |
| 负债和股东权益合计 | 7,079,578,187.53 | 7,087,092,443.91 | 7,265,143,471.02 | 7,258,848,256.72 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,807,493,887.32 | 1,866,790,913.84 | 833,276,755.41 | 3,666,105,503.32 |
| 经营活动现金流出小计 | 2,192,937,707.83 | 1,506,975,961.74 | 698,491,943.77 | 3,418,627,498.55 |
| 经营活动产生的现金流量净额 | 614,556,179.49 | 359,814,952.1 | 134,784,811.64 | 247,478,004.77 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 8,739,921.03 | 4,885,249.54 | 1,909,552.58 | 13,432,230.77 |
| 投资活动现金流出小计 | 122,857,376.84 | 83,487,908.05 | 43,567,901.7 | 209,573,996.22 |
| 投资活动产生的现金流量净额 | -114,117,455.81 | -78,602,658.51 | -41,658,349.12 | -196,141,765.45 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 289,500,000 | 167,500,000 | 100,000,000 | 416,295,752 |
| 筹资活动现金流出小计 | 724,067,037.94 | 443,067,464.68 | 149,954,780.77 | 677,506,079.42 |
| 筹资活动产生的现金流量净额 | -434,567,037.94 | -275,567,464.68 | -49,954,780.77 | -261,210,327.42 |
| 汇率变动对现金及现金等价物的影响 | -52,165,179.77 | -32,098,902.51 | -20,621,336.92 | 25,614,564.1 |
| 现金及现金等价物净增加额 | 13,706,505.97 | -26,454,073.6 | 22,550,344.83 | -184,259,524 |
| 期末现金及现金等价物余额 | 1,204,920,622.72 | 1,164,760,043.15 | 1,213,764,461.58 | 1,191,872,623.75 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -26,454,073.6 | - | -184,259,524 |
最新报告期：2026-09-24| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中泰证券 | 祝嘉琦 | 0.50 | 0.55 | 0.61 | 2026-09-24 |
| 东方证券 | 伍云飞 | 0.50 | 0.60 | 0.70 | 2026-09-12 |
| 浙商证券 | 盖文化,郭双喜 | 0.48 | 0.54 | 0.65 | 2026-09-07 |
| 华创证券 | 郑辰,王宏雨 | 0.50 | 0.60 | 0.72 | 2026-09-02 |
| 中金公司 | 俞波,张琎,吴婉桦 | 0.47 | 0.55 | -- | 2026-08-30 |